July 24, 2025 – The FDA has approved a new treatment as the first and only skin cream for a specific type of hand eczema that affects about 1 in every 10 people globally. The cream, sold under the ...
Results of a phase 2 trial suggest that ruxolitinib cream 1.5% may be an effective treatment option for adults with nonatopic chronic hand eczema.
The Committee on Chemists with Disabilities is planning to showcase 50 braille periodic tables in 50 states by their 50th ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback